ALLIN IP DX LLC NPI 1467820191

NPI Details

ALLIN IP DX LLC is a clinical medical laboratory in Sarasota, FL. The provider is (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology. ALLIN IP DX LLC NPI is 1467820191. The provider is registered as an organization entity type.
The provider Is Doing Business As Dba - Lab Services, Llc.

The provider's business location address is:

1 S SCHOOL AVE STE 900
SARASOTA, FL
ZIP 34237-045
Phone: (941) 413-5974

The provider's authorized official is Michael Fitch .
The authorized official title is President and has the following contact phone number (941) 413-5974.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS:87426)
• Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source (HCPCS:G2023)
• Gene analysis (cytochrome p450, family 2, subfamily d, polypeptide 6) common variants (HCPCS:81226)
• Gene analysis (cytochrome p450, family 2, subfamily c, polypeptide 19) common variants (HCPCS:81225)
• Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
• Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
• Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
• Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique (HCPCS:87651)
• Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique (HCPCS:87653)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique (HCPCS:87500)
• Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique (HCPCS:87641)
• Molecular pathology procedure level 6 genetic analysis (HCPCS:81405)
• Molecular pathology procedure level 4 (HCPCS:81403)
• Molecular pathology procedure level 5 (HCPCS:81404)
• Gene analysis (frataxin) of full sequence (HCPCS:81286)
• Gene analysis (calcium voltage-gated channel subunit alpha1 a) for abnormal alleles (HCPCS:81184)
• Molecular pathology procedure level 1 (HCPCS:81400)
• Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique (HCPCS:87491)
• Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique (HCPCS:87591)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique (HCPCS:87661)
• Detection test for gardnerella vaginalis (bacteria), amplified probe technique (HCPCS:87511)
• Gene analysis (solute carrier organic anion transporter family, member 1b1) for common variant (HCPCS:81328)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Detection test by nucleic acid for legionella pneumophila (water borne bacteria), amplified probe technique (HCPCS:87541)
• Detection test by nucleic acid for mycoplasma pneumoniae (bacteria), amplified probe technique (HCPCS:87581)
• Detection test by nucleic acid for chlamydia pneumoniae, amplified probe technique (HCPCS:87486)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Gene analysis (coagulation factor ix) full sequence analysis (HCPCS:81238)
• Gene analysis (glucosidase, beta, acid) common variants (HCPCS:81251)
• Hemoglobin a1c level (HCPCS:83036)
• Test for detecting genes associated with colon cancer, genomic sequence analysis panel, at least 10 genes (HCPCS:81435)
• Test for detecting genes associated with colon cancer, duplication/deletion analysis panel, at least 5 genes (HCPCS:81436)
• Gene analysis (neuroendocrine tumors), genomic sequence (HCPCS:81437)
• Gene analysis (neuroendocrine tumors), duplication and deletion variants (HCPCS:81438)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)

The enumeration date for this NPI number is 9/11/2015 and was last updated on 9/24/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: